KEGG DRUG

Search results

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY	Disease ID
1	ABP 959 - biosimilar to eculizumab	[1] Eculizumab	[1] D03940 (Name: Eculizumab)	[1] C5 💬	[10] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	[1] 62
2	ABP 959 - proposed biosimilar to eculizumab	[1] Eculizumab	[1] D03940 (Name: Eculizumab)	[1] C5 💬	[10] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	[1] 62
3	ECULIZUMAB	[1] Eculizumab	[1] D03940 (Name: Eculizumab)	[1] C5 💬	[10] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	[7] 11, 13, 14, 61, 62, 109, 222
4	Other: Blood collection for measurement of eculizumab peak concentrations	[1] Eculizumab	[1] D03940 (Name: Eculizumab)	[1] C5 💬	[10] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	[1] 62
5	Other: Eculizumab	[1] Eculizumab	[1] D03940 (Name: Eculizumab)	[1] C5 💬	[10] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	[1] 109
6	SB12 (proposed eculizumab biosimilar)	[1] Eculizumab	[1] D03940 (Name: Eculizumab)	[1] C5 💬	[10] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	[1] 62
7	Soliris (eculizumab)	[1] Eculizumab	[1] D03940 (Name: Eculizumab)	[1] C5 💬	[10] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	[1] 62
8	SOLIRIS® (eculizumab) injection, for intravenous use	[1] Eculizumab	[1] D03940 (Name: Eculizumab)	[1] C5 💬	[10] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	[1] 62